Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Enzo Life Sciences alpha Gal Epitope (Galalpha1-3Galbeta1-4GlcNAc-R) monoclonal antibody (M86) (1 Vial)
SDP

Supplier:  Enzo Life Sciences ALX8010901

Encompass_Preferred

Clone: M86. Host: Mouse. Isotype: IgM. Immunogen: Rabbit red blood cell membrane. Source: Hybridoma tissue culture. Species Reactivity: Mouse, Rat, Porcine. Specificity: Recognizes synthetic and naturally produced mouse, rat and pig Galα1-3Gal epitopes on glycoproteins and glycolipids. Crossreactivity: Does not cross-react with β-Gal glycoproteins or BSA. Applications: ELISA. Flow Cytometry, IHC (PS), WB. FUNC. Recommended dilutions: Note: Do not use non-fat milk for blocking! Many blocking agents from non-human mammal. Sources will cross-react with the antibody. Appropriate antibody dilution may vary from lot to lot. An initial dilution of 1:5 is recommended. Suggested dilutions/conditions may not be available for all applications. Optimal conditions must be determined individually for each application. Formulation: Liquid. Tissue culture supernatant. Handling: Avoid freeze/thaw cycles. After opening, prepare aliquots and store at -20°C.

Catalog No. NC0277743


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.